KalVista Pharmaceuticals
KALV
#7116
Rank
C$0.61 B
Marketcap
$12.54
Share price
-0.40%
Change (1 day)
-28.13%
Change (1 year)

EPS for KalVista Pharmaceuticals (KALV)

EPS in 2023 (TTM): -$4.26

According to KalVista Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$4.55. In 2022 the company made an earnings per share (EPS) of -$5.38 a decrease over its 2021 EPS that were of -$3.84.

EPS history for KalVista Pharmaceuticals from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.26-20.83%
2022-$5.3840.07%
2021-$3.8428.37%
2020-$2.9941.5%
2019-$2.1218.55%
2018-$1.78-49.8%
2017-$3.55
2015-$21.76-6.99%
2014-$23.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.14-31.01%๐Ÿ‡บ๐Ÿ‡ธ USA